Company Profiles

driven by the PitchBook Platform

Presage Biosciences

Description

Developer of a healthcare technology platform designed to improve the cancer drug development process. The company's healthcare technology platform uses CIVO technology to deliver pharmacologically appropriate concentrations of multiple drugs to different regions of a tumor and precisely evaluate patient's unique responses to micro doses of multiple cancer drugs, enabling drug researchers to test experimental drugs in human patients years earlier than possible with conventional means.

2008

Founded

PRIVATE

Status

11-50

Employees

Grant

Latest Deal Type

$2.72M

Latest Deal Amount

$22.9M

Total Amount Raised

Description

Developer of a healthcare technology platform designed to improve the cancer drug development process. The company's healthcare technology platform uses CIVO technology to deliver pharmacologically appropriate concentrations of multiple drugs to different regions of a tumor and precisely evaluate patient's unique responses to micro doses of multiple cancer drugs, enabling drug researchers to test experimental drugs in human patients years earlier than possible with conventional means.

Website:

www.presagebio.com

Formerly Known As

Presage Therapeutics

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery
Drug Delivery

Primary Office

530 Fairview Avenue North Suite 1000 Seattle, WA 98109United States +1 (800) 530-5404
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Presage Biosciences's full profile, request a free trial.

Presage Biosciences Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Presage Biosciences Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Presage Biosciences Investors (7)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
CelgeneCorporationMinority000 0000000 0000
Clifford StocksAngel (individual)Minority000 0000000 0000
David WuAngel (individual)Minority000 0000000 0000
Denny Hill CapitalVenture CapitalMinority000 0000000 0000
National Institutes of HealthGovernment000 0000000 0000
Celgene Corporation
Clifford Stocks Angel (individual)
David Wu Angel (individual)
Denny Hill Capital Venture Capital
National Institutes of Health Government

Presage Biosciences Executive Team (3)

NameTitleBoard
Seat
Contact
Info
Nathan CaffoPresident
Richard Klinghoffer Ph.DChief Scientific Officer
Michael JacksonVice President of Finance & Administration
Nathan Caffo President
Richard Klinghoffer Ph.D Chief Scientific Officer
Michael Jackson Vice President of Finance & Administration

Presage Biosciences Board Members (6)

NameRepresentingRoleSinceContact
Info
Bradley MargusSelfBoard Member000 0000
Christoph Lengauer Ph.DSelfBoard Member000 0000
David JohnsonPresage BiosciencesBoard Member000 0000
James Olson Ph.DSelfCo-Founder & Chairman000 0000
Kenneth Nussbacher JDPresage BiosciencesBoard Member000 0000
Bradley Margus Board Member Self
Christoph Lengauer Ph.D Board Member Self
David Johnson Board Member Presage Biosciences
James Olson Ph.D Co-Founder & Chairman Self
Kenneth Nussbacher JD Board Member Presage Biosciences
Request full access to PitchBook